載入...
Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib
BACKGROUND: We report a case of severe bilateral panuveitis during melanoma therapy with a combination of Dabrafenib, a B-raf (BRAF) inhibitor, and Trametinib, a mitogen/extracellular signal-regulated kinase (MEK) inhibitor. Both of these drugs are effectors in the mitogen-activated protein kinase (...
Na minha lista:
| 發表在: | J Ophthalmic Inflamm Infect |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Berlin Heidelberg
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4460117/ https://ncbi.nlm.nih.gov/pubmed/26078801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12348-015-0049-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|